Amol Narang

5.4k total citations · 1 hit paper
140 papers, 2.1k citations indexed

About

Amol Narang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Amol Narang has authored 140 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Oncology, 53 papers in Pulmonary and Respiratory Medicine and 30 papers in Surgery. Recurrent topics in Amol Narang's work include Pancreatic and Hepatic Oncology Research (79 papers), Advanced Radiotherapy Techniques (27 papers) and Cancer Genomics and Diagnostics (27 papers). Amol Narang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (79 papers), Advanced Radiotherapy Techniques (27 papers) and Cancer Genomics and Diagnostics (27 papers). Amol Narang collaborates with scholars based in United States, South Korea and United Kingdom. Amol Narang's co-authors include Joseph M. Herman, Daniel A. Laheru, Lei Zheng, Christopher L. Wolfgang, Jin He, Ralph H. Hruban, John L. Cameron, Matthew J. Weiss, Richard A. Burkhart and Elliot K. Fishman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Amol Narang

125 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection

2018 271 citations Vincent P. Groot, Daniel A. Laheru et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amol Narang United States	21	1.2k	705	496	365	341	140	2.1k
Ethan B. Ludmir United States	22	809 0.7×	750 1.1×	575 1.2×	207 0.6×	225 0.7×	194	2.1k
Arya Amini United States	23	850 0.7×	1.0k 1.5×	621 1.3×	242 0.7×	215 0.6×	108	2.1k
Sungjin Kim United States	25	610 0.5×	641 0.9×	574 1.2×	252 0.7×	203 0.6×	89	1.9k
Cheuk‐Wai Choi Hong Kong	26	1.2k 1.0×	908 1.3×	1.2k 2.4×	323 0.9×	244 0.7×	103	2.8k
Shrujal S. Baxi United States	28	1.6k 1.3×	769 1.1×	775 1.6×	180 0.5×	188 0.6×	107	2.7k
James P. Morden United Kingdom	17	848 0.7×	1.1k 1.5×	627 1.3×	658 1.8×	375 1.1×	51	2.6k
Matthew S. Ning United States	19	544 0.5×	608 0.9×	211 0.4×	100 0.3×	215 0.6×	89	1.4k
Nuran Beşe Türkiye	19	672 0.6×	292 0.4×	196 0.4×	228 0.6×	253 0.7×	44	1.3k
A. William Blackstock United States	31	1.7k 1.4×	1.7k 2.5×	711 1.4×	350 1.0×	479 1.4×	129	3.1k
Zachary S. Zumsteg United States	32	982 0.8×	1.9k 2.8×	1.1k 2.2×	475 1.3×	368 1.1×	116	3.8k

Countries citing papers authored by Amol Narang

Since Specialization

Citations

This map shows the geographic impact of Amol Narang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amol Narang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amol Narang more than expected).

Fields of papers citing papers by Amol Narang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amol Narang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amol Narang. The network helps show where Amol Narang may publish in the future.

Co-authorship network of co-authors of Amol Narang

This figure shows the co-authorship network connecting the top 25 collaborators of Amol Narang. A scholar is included among the top collaborators of Amol Narang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amol Narang. Amol Narang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hacker‐Prietz, Amy, et al.. (2024). Variation in outcomes and practice patterns among patients with localized pancreatic cancer: the impact of the pancreatic cancer multidisciplinary clinic. Frontiers in Oncology. 14. 1427775–1427775.

Wang, Junke, Jie Yang, Amol Narang, et al.. (2024). Consensus, debate, and prospective on pancreatic cancer treatments. Journal of Hematology & Oncology. 17(1). 92–92. 39 indexed citations

Bhutani, Manoop S., Amol Narang, Kai Ding, et al.. (2024). EUS-guided hydrogel injection to separate pancreatic head carcinoma from duodenum for enhanced radiotherapy: Multi-site feasibility study. SHILAP Revista de lepidopterología. 12(7). E861–E867. 1 indexed citations

Alden, Stephanie, Valerie Lee, Amol Narang, et al.. (2024). Circulating Tumor DNA to Predict Radiographic and Pathologic Response to Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer. The Oncologist. 29(3). e414–e418. 6 indexed citations

Voong, Khinh Ranh, Siyao Li, Chen Hu, et al.. (2024). Routine review of patient-reported outcome data influences radiotherapy care: IMPROVE study results. Radiotherapy and Oncology. 203. 110688–110688.

Zheng, Lei, Dan Laheru, Ana De Jesus‐Acosta, et al.. (2024). Outcomes in patients with pancreatic and ampullary cancer whose tumors harbor pathogenic APC mutations.. Journal of Clinical Oncology. 42(3_suppl). 693–693.

Gogineni, Emile, Hao Chen, Alexandra C. Istl, et al.. (2023). Comparative In Silico Analysis of Ultra-Hypofractionated Intensity-Modulated Photon Radiotherapy (IMRT) Versus Intensity-Modulated Proton Therapy (IMPT) in the Pre-Operative Treatment of Retroperitoneal Sarcoma. Cancers. 15(13). 3482–3482. 1 indexed citations

Lin, Timothy A., et al.. (2023). Utilization of the Triangle Volume in Patients with Localized PDAC Undergoing Pre-Operative SBRT: Report of Early Outcomes. International Journal of Radiation Oncology*Biology*Physics. 117(2). S14–S14. 2 indexed citations

Narang, Amol, Theodore S. Hong, Kai Ding, et al.. (2023). A Multi-Institutional Safety and Feasibility Study Exploring the Use of Hydrogel to Create Spatial Separation between the Pancreas and Duodenum in Patients with Pancreatic Cancer. Practical Radiation Oncology. 14(4). e276–e282. 4 indexed citations

10.

Porter, Nancy, Daniel A. Laheru, Bryan Lau, et al.. (2022). Risk of Pancreatic Cancer in the Long-Term Prospective Follow-Up of Familial Pancreatic Cancer Kindreds. JNCI Journal of the National Cancer Institute. 114(12). 1681–1688. 19 indexed citations

11.

Hill, Colin, Lei Zheng, Jin He, et al.. (2022). Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy. Radiation Oncology Journal. 40(2). 111–119. 13 indexed citations

12.

Youssefian, Sina, Amol Narang, Eun Ji Shin, et al.. (2022). Finite Element-Based Personalized Simulation of Duodenal Hydrogel Spacer: Spacer Location Dependent Duodenal Sparing and a Decision Support System for Spacer-Enabled Pancreatic Cancer Radiation Therapy. Frontiers in Oncology. 12. 833231–833231. 9 indexed citations

13.

Hazell, Sarah Z., Wei Fu, Chen Hu, et al.. (2021). Longitudinal Trends of Financial Toxicity in Patients With Lung Cancer: A Prospective Cohort Study. JCO Oncology Practice. 17(8). e1094–e1109. 34 indexed citations

14.

Hill, Colin, Jin He, Lei Zheng, et al.. (2021). High neutrophil-to-lymphocyte ratio following stereotactic body radiation therapy is associated with poor clinical outcomes in patients with borderline resectable and locally advanced pancreatic cancer. Journal of Gastrointestinal Oncology. 13(1). 368–379. 11 indexed citations

15.

Herman, Joseph M., Helen Kitchen, Arnold Degboe, et al.. (2019). Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessment. Quality of Life Research. 28(11). 2929–2939. 12 indexed citations

16.

Peng, Luke, Amol Narang, Noura Radwan, et al.. (2018). Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy. Urologic Oncology Seminars and Original Investigations. 36(6). 309.e7–309.e14. 9 indexed citations

17.

Ryan, John F., Vincent P. Groot, Lauren M. Rosati, et al.. (2017). Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and Effective. Annals of Surgical Oncology. 25(1). 280–289. 25 indexed citations

18.

Shen, Colette J., Matthew Ladra, Amol Narang, & Stephanie A. Terezakis. (2016). Effect of Socioeconomic and Racial Factors in Selection of Proton Radiation Therapy for Pediatric Patients: Analysis of the National Cancer Data Base. International Journal of Radiation Oncology*Biology*Physics. 96(2). S35–S36. 1 indexed citations

19.

Narang, Amol. (2003). Oral health and related factors in cystic fibrosis and other chronic respiratory disorders. Archives of Disease in Childhood. 88(8). 702–707. 54 indexed citations

20.

Joshi, V V, et al.. (1979). Renal microvascular thrombosis with cortical necrosis in haemolytic uraemic syndrome in association with acute infectious colitis.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 16(9). 749–54. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact